Repurposing Drugs via Network Analysis: Opportunities for Psychiatric Disorders.
PMID:35890359
A Novel Based-Network Strategy to Identify Phytochemicals from Radix Salviae Miltiorrhizae (Danshen) for Treating Alzheimer's Disease.
PMID:35889336
Using BERT to identify drug-target interactions from whole PubMed.
PMID:35729494
Bioinformatic Analysis of the Perilymph Proteome to Generate a Human Protein Atlas.
PMID:35573665
Gene-SCOUT: identifying genes with similar continuous trait fingerprints from phenome-wide association analyses.
PMID:35474393
Application of Transcriptomics for Predicting Protein Interaction Networks, Drug Targets and Drug Candidates.
PMID:35356062
Systematic illumination of druggable genes in cancer genomes.
PMID:35196490
Machine learning prediction and tau-based screening identifies potential Alzheimer's disease genes relevant to immunity.
PMID:35149761
A functional genomic approach to actionable gene fusions for precision oncology.
PMID:35138907
Receptor-interacting protein kinase 2 (RIPK2) stabilizes c-Myc and is a therapeutic target in prostate cancer metastasis.
PMID:35115556
Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.
PMID:35044719
Worldwide Protein Data Bank (wwPDB): A virtual treasure for research in biotechnology.
PMID:34908533
RCSB Protein Data Bank resources for structure-facilitated design of mRNA vaccines for existing and emerging viral pathogens.
PMID:34739839
Knowledge-based approaches to drug discovery for rare diseases.
PMID:34718207
Natural products for infectious microbes and diseases: an overview of sources, compounds, and chemical diversities.
PMID:34705221
Transcriptomic profiling in canines and humans reveals cancer specific gene modules and biological mechanisms common to both species.
PMID:34570764
Single-Cell RNA-Seq of Cisplatin-Treated Adult Stria Vascularis Identifies Cell Type-Specific Regulatory Networks and Novel Therapeutic Gene Targets.
PMID:34566577
KinOrtho: a method for mapping human kinase orthologs across the tree of life and illuminating understudied kinases.
PMID:34537014
Proteomic signatures of myeloid derived suppressor cells from liver and lung metastases reveal functional divergence and potential therapeutic targets.
PMID:34482371
Non-canonical role of Hippo tumor suppressor serine/threonine kinase 3 STK3 in prostate cancer.
PMID:34450249
Hypotheses and facts for genetic factors related to severe COVID-19.
PMID:34367930
Transcriptomics-Based Phenotypic Screening Supports Drug Discovery in Human Glioblastoma Cells.
PMID:34359681
Recent advances in drug repurposing using machine learning.
PMID:34274565
Crowdsourced mapping of unexplored target space of kinase inhibitors.
PMID:34083538
Towards a RIOK2 chemical probe: cellular potency improvement of a selective 2-(acylamino)pyridine series.
PMID:34046605
PhenCards: a data resource linking human phenotype information to biomedical knowledge.
PMID:34034817
High ELF4 expression in human cancers is associated with worse disease outcomes and increased resistance to anticancer drugs.
PMID:33836003
Bioinformatic Analysis of Structure and Function of LIM Domains of Human Zyxin Family Proteins.
PMID:33808029
SmartGraph: a network pharmacology investigation platform.
PMID:33430980
Genetic mechanisms of critical illness in COVID-19.
PMID:33307546
An Automated Functional Annotation Pipeline That Rapidly Prioritizes Clinically Relevant Genes for Autism Spectrum Disorder.
PMID:33261099
Integration of the Drug-Gene Interaction Database (DGIdb 4.0) with open crowdsource efforts.
PMID:33237278
Moving targets in drug discovery.
PMID:33214619
RCSB Protein Data Bank: powerful new tools for exploring 3D structures of biological macromolecules for basic and applied research and education in fundamental biology, biomedicine, biotechnology, bioengineering and energy sciences.
PMID:33211854
The Clinical Kinase Index: A Method to Prioritize Understudied Kinases as Drug Targets for the Treatment of Cancer.
PMID:33205077
Open Targets Platform: supporting systematic drug-target identification and prioritisation.
PMID:33196847
Quantitative Structure-Mutation-Activity Relationship Tests (QSMART) model for protein kinase inhibitor response prediction.
PMID:33183223
A Workflow of Integrated Resources to Catalyze Network Pharmacology Driven COVID-19 Research.
PMID:33173863
TCRD and Pharos 2021: mining the human proteome for disease biology.
PMID:33156327
DrugCentral 2021 supports drug discovery and repositioning.
PMID:33151287
Reconstructed signaling and regulatory networks identify potential drugs for SARS-CoV-2 infection.
PMID:33083801
The Dark Kinase Knowledgebase: an online compendium of knowledge and experimental results of understudied kinases.
PMID:33079988
PKIS deep dive yields a chemical starting point for dark kinases and a cell active BRSK2 inhibitor.
PMID:32985588
Deciphering the Plasma Proteome of Type 2 Diabetes.
PMID:32928870
Multiomics dissection of molecular regulatory mechanisms underlying autoimmune-associated noncoding SNPs.
PMID:32879140
TargetDB: A target information aggregation tool and tractability predictor.
PMID:32877430
Large-scale discovery of male reproductive tract-specific genes through analysis of RNA-seq datasets.
PMID:32814578
A novel screening approach comparing kinase activity of small molecule inhibitors with similar molecular structures and distinct biologic effects in triple-negative breast cancer to identify targetable signaling pathways.
PMID:32796402
Systematic Characterization of Recurrent Genomic Alterations in Cyclin-Dependent Kinases Reveals Potential Therapeutic Strategies for Cancer Treatment.
PMID:32668240
Applications of single-cell sequencing for the field of otolaryngology: A contemporary review.
PMID:32596483
Homology Modeling of TMPRSS2 Yields Candidate Drugs That May Inhibit Entry of SARS-CoV-2 into Human Cells.
PMID:32511288
Extending the small-molecule similarity principle to all levels of biology with the Chemical Checker.
PMID:32440005
ThETA: transcriptome-driven efficacy estimates for gene-based TArget discovery.
PMID:32437556
Towards the routine use of in silico screenings for drug discovery using metabolic modelling.
PMID:32369553
QSAR without borders.
PMID:32356548
EnrichrBot: Twitter bot tracking tweets about human genes.
PMID:32277816
Ellagic Acid, Kaempferol, and Quercetin from Acacia nilotica: Promising Combined Drug With Multiple Mechanisms of Action.
PMID:32226726
Exploration of databases and methods supporting drug repurposing: a comprehensive survey.
PMID:32055842
Machine learning approaches and databases for prediction of drug-target interaction: a survey paper.
PMID:31950972
Single Cell and Single Nucleus RNA-Seq Reveal Cellular Heterogeneity and Homeostatic Regulatory Networks in Adult Mouse Stria Vascularis.
PMID:31920542
How to Illuminate the Druggable Genome Using Pharos.
PMID:31898878
Novel approaches leading towards peptide GPCR de-orphanisation.
PMID:31863461
Therapies for rare diseases: therapeutic modalities, progress and challenges ahead.
PMID:31836861
An omics perspective on drug target discovery platforms.
PMID:31774113
Pathway Commons 2019 Update: integration, analysis and exploration of pathway data.
PMID:31647099
Prioritizing target-disease associations with novel safety and efficacy scoring methods.
PMID:31285471
Exploring the dark genome: implications for precision medicine.
PMID:31270560
In Silico Toxicology Data Resources to Support Read-Across and (Q)SAR.
PMID:31244651
Sepsis in the era of data-driven medicine: personalizing risks, diagnoses, treatments and prognoses.
PMID:31190075
Geneshot: search engine for ranking genes from arbitrary text queries.
PMID:31114885
Tissue-specific genes as an underutilized resource in drug discovery.
PMID:31076736
Predicting synthetic lethal interactions using conserved patterns in protein interaction networks.
PMID:30995217
Using genetic drug-target networks to develop new drug hypotheses for major depressive disorder.
PMID:30877270
Assessing the public landscape of clinical-stage pharmaceuticals through freely available online databases.
PMID:30690196
A Chemoproteomic Strategy for Direct and Proteome-Wide Covalent Inhibitor Target-Site Identification.
PMID:30518210
Open Targets Platform: new developments and updates two years on.
PMID:30462303
Cytoscape StringApp: Network Analysis and Visualization of Proteomics Data.
PMID:30450911
ChEMBL: towards direct deposition of bioassay data.
PMID:30398643
DrugThatGene: integrative analysis to streamline the identification of druggable genes, pathways and protein complexes from CRISPR screens.
PMID:30395160
DrugCentral 2018: an update.
PMID:30371892
Network, Transcriptomic and Genomic Features Differentiate Genes Relevant for Drug Response.
PMID:30319692
Context-enriched interactome powered by proteomics helps the identification of novel regulators of macrophage activation.
PMID:30303482
Uncovering new disease indications for G-protein coupled receptors and their endogenous ligands.
PMID:30285606
A Pharmacochaperone-Based High-Throughput Screening Assay for the Discovery of Chemical Probes of Orphan Receptors.
PMID:30251873
Identification of Novel Target for Osteosarcoma by Network Analysis.
PMID:30144309
Integrative landscape of dysregulated signaling pathways of clinically distinct pancreatic cancer subtypes.
PMID:30018740
Genetic-Driven Druggable Target Identification and Validation.
PMID:29803319
How to Achieve Better Results Using PASS-Based Virtual Screening: Case Study for Kinase Inhibitors.
PMID:29755970
Integrative annotation and knowledge discovery of kinase post-translational modifications and cancer-associated mutations through federated protein ontologies and resources.
PMID:29695735
Current Challenges and Opportunities in Treating Glioblastoma.
PMID:29669750
Proteomic analysis defines kinase taxonomies specific for subtypes of breast cancer.
PMID:29643987
TISSUES 2.0: an integrative web resource on mammalian tissue expression.
PMID:29617745
Drug Repositioning in Glioblastoma: A Pathway Perspective.
PMID:29615902
Unexplored therapeutic opportunities in the human genome.
PMID:29472638
Glimmers in illuminating the druggable genome.
PMID:29348682
Drug target ontology to classify and integrate drug discovery data.
PMID:29122012
Evidence-Based Precision Oncology with the Cancer Targetome.
PMID:28964549
Computational Approaches to Identify Genetic Interactions for Cancer Therapeutics.
PMID:28941356
Using ChEMBL web services for building applications and data processing workflows relevant to drug discovery.
PMID:28602100
Bioinformatics in translational drug discovery.
PMID:28487472
TIN-X: target importance and novelty explorer.
PMID:28398460
The ChEMBL database in 2017.
PMID:27899562